Senior Medical Scientist - US Medical - Oncology (Neulasta)

The US Medical Senior Medical Scientist for a US Product supports the implementation of US Medical strategies, including US launch and lifecycle management.

Join our team as we enter an era of oncology drug development that will usher in new wave of advances that promise to transform cancer care.

This role is responsible for:

• Supporting the development and execution of US product medical strategy, via the US Medical Plan, including launch support and lifecycle management, in alignment with Global Medical strategy
• Supporting development of local evidence generation plan in alignment with Global Medical Strategy
• Supporting the development and implementation of Medical Affairs clinical studies.
• Participating in engagement of external key stakeholders (often in partnership with other
• functions)
• Participates with the MAC operating committee in the material reviews.
• Supports or implements external Stakeholder Strategy Engagement strategy and execution with medical experts, professional societies, patient groups and other key stakeholders
• Participates in the review of investigator sponsored studies
• Medical / Scientific contribution to Value Dossiers, compendia and interactions with payers in collaboration with VA&P
• Executes product-specific US evidence generation strategy, in alignment with EGT, and supports execution of data communication strategy
• Provides input into medical and scientific insight for incorporation into US product strategies
• Builds Amgen's reputation as a science-based and patient-focused reliable partner

Basic Qualifications

MD or DO degree from an accredited medical school OR PhD OR PharmD

Preferred Qualifications

• MD plus accredited fellowship in Hematology-Oncology, board certified or board eligible
• 2+ years of Medical Affairs experience in the pharma/biotech industry
• 2+ years of patient clinical experience in Hematology-Oncology
• 2+ years of clinical research experience in Hematology-Oncology

We provide the opportunities, resources and rewards of a global enterprise, with the verve of an early biotechnology pioneer.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

#LI-POST

MD01